Geofrey Amanya

Mr. Geofrey Amanya

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 June 2017 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
GAGeofrey Amanya
Geofrey Amanya
SKSamuel Kizito
Samuel Kizito
INImmaculate Nabukenya
Immaculate Nabukenya
JKJoan Kalyango
Joan Kalyango
CACollins Atuheire
Collins Atuheire
CKCharles Karamagi
Charles Karamagi
Hepatitis E is self-limiting, but can cause death in most at risk groups like pregnant women and those with preexisting acute liver disease. In developing countries it presents as epidemic, in 2014 Hepatitis E Virus (HEV) outbreak was reported in Napak district Uganda. The role of factors in this setting that might have propagated this HEV epidemic, including host, agent, and environmental characteristics, were still not clear. This study was therefore conducted to investigate the risk factors, person, place and time characteristics, associated with the hepatitis E virus (HEV) epidemic in Napak district. Review of line lists data for epidemiological description and matched case control study on neighborhood and age in the ratio of 1:2 were used to assess risk factors for HEV outbreak in Napak. Cluster and random sampling were used to obtain a sample size of 332, (111 cases, 221 controls). Possible interaction and confounding was assessed using conditional logistic regression. Over 1359 cases and 30 deaths were reported during 2013/2014 HEV outbreak. The mean age of patients was 29 ± years, 57.9% of cases were females. Overall case Fatality Ratio was 2.2% in general population but 65.2% in pregnant women. More than 94% of the cases were reported in the sub counties of Napak, 5.7% of cases were reported in the outside neighboring districts. The epidemic peaked in January 2014 and gradually subsided by December 2014. Risk factors found to be associated with HEV included drinking untreated water (OR 6.69, 95% CI 3.15–14.16), eating roadside food (OR 6.11, 95% CI 2.85–13.09), reported not cleaning utensils (OR 3.24, 95% CI 1.55–1.76), and being a hunter (OR 1.14, 95% CI 1.03–12.66). The results of this study suggest that the virus is transmitted by the feco-oral route through contaminated water. They also suggest that active surveillance and appropriate measures targeting community and routine individual health actions are important to prevent transmission and decrease the deaths.

Ahmad AlkhatibAhmad Alkhatib
Ahmad Alkhatib
LNLawrence Nnyanzi
Lawrence Nnyanzi
BMBrian Mujuni
Brian Mujuni
GAGeofrey Amanya
Geofrey Amanya
CICharles Ibingira
Charles Ibingira
Objectives: Low and Middle-Income Countries are experiencing a fast-paced epidemiological rise in clusters of non-communicable diseases such as diabetes and cardiovascular disease, forming an imminent rise in multimorbidity. However, preventing multimorbidity has received little attention in LMICs, especially in Sub-Saharan African Countries. Methods: Narrative review which scoped the most recent evidence in LMICs about multimorbidity determinants and appropriated them for potential multimorbidity prevention strategies. Results: MMD in LMICs is affected by several determinants including increased age, female sex, environment, lower socio-economic status, obesity, and lifestyle behaviours, especially poor nutrition, and physical inactivity. Multimorbidity public health interventions in LMICs, especially in Sub-Saharan Africa are currently impeded by local and regional economic disparity, underdeveloped healthcare systems, and concurrent prevalence of communicable and non-communicable diseases. However, lifestyle interventions that are targeted towards preventing highly prevalent multimorbidity clusters, especially hypertension, diabetes, and cardiovascular disease, can provide early prevention of multimorbidity, especially within Sub-Saharan African countries with emerging economies and socio-economic disparity. Conclusion: Future public health initiatives should consider targeted lifestyle interventions and appropriate policies and guidelines in preventing multimorbidity in LMICs.

27 December 2022 in African Health Sciences
Verified
Journal Article
Open access
PDF file
SKSamuel Kizito
Samuel Kizito
RNRita Nakalega
Rita Nakalega
DNDorothy Nampijja
Dorothy Nampijja
CACollins Atuheire
Collins Atuheire
GAGeofrey Amanya
Geofrey Amanya
CKCharles Karamagi
Charles Karamagi
Background: There is uncertainty about the actual burden of childhood TB in Uganda, but underestimation is acknowledged. We aimed at determining prevalence, factors associated with PTB among children attending PHC facilities in Kampala. Methods: This was a cross-sectional study of 255 children, with presumed TB, attending six health facilities in Kampala, Uganda, in March 2015. Socio-demographic, clinical, and laboratory data were collected using a questionnaire. TB was diagnosed using “Desk Guide” algorithms. Sputum based on ZN/FM and/or Gene-Xpert. Logistic regression was used to assess associations with outcomes. Results: Overall, prevalence of PTB 13.7 % (2.6 – 24.8). Among HIV-positive, the prevalence of PTB was 41.7%, while among malnourished children, 21.7% and contacts, 89.3%. The factors that influenced PTB included: tobacco smoker at home (OR =1.6, 95 % CI: 1.07 – 6.86), stunting (OR = 2.2, 95 % CI: 1.01 – 4.15). Only 5.3% of the smear-negative TB children and 81.3% of the smear-positive children were initiated on treatment within a month of diagnosis. Conclusion: Clinical TB among children is underdiagnosed and undertreated. There is a need for more sensitive and specific diagnostic tests, need ways to disseminate and promote uptake of standardized clinical algorithms. Also, contact TB tracing should be strengthened so that such cases can be actively detected even at community level. Keywords: Pediatric; pulmonary; tuberculosis.

12 May 2024 in Cost Effectiveness and Resource Allocation
Verified
Journal Article
Open access
PDF file
GAGeofrey Amanya
Geofrey Amanya
MWMichael L. Washington
Michael L. Washington
DKDaniel Kadobera
Daniel Kadobera
MRMigisha Richard
Migisha Richard
ANAlex Ndyabakiira
Alex Ndyabakiira
JHJulie Harris
Julie Harris
Introduction: Early during the COVID-19 outbreak, various approaches were utilized to prevent COVID-19 introductions from incoming airport travellers. However, the costs and effectiveness of airport-specific interventions have not been evaluated. Methods: We evaluated policy options for COVID-19-specific interventions at Entebbe International Airport for costs and impact on COVID-19 case counts, we took the government payer perspective. Policy options included; (1)no screening, testing, or mandatory quarantine for any incoming traveller; (2)mandatory symptom screening for all incoming travellers with RT-PCR testing only for the symptomatic and isolation of positives; and (3)mandatory 14-day quarantine and one-time testing for all, with 10-day isolation of persons testing positive. We calculated incremental cost-effectiveness ratios (ICERs) in US$ per additional case averted. Results: Expected costs per incoming traveller were $0 (Option 1), $19 (Option 2), and $766 (Option 3). ICERs per case averted were $257 for Option 2 (which averted 4,948 cases), and $10,139 for Option 3 (which averted 5,097 cases) compared with Option I. Two-week costs were $0 for Option 1, $1,271,431 Option 2, and $51,684,999 Option 3. The per-case ICER decreased with increase in prevalence. The cost-effectiveness of our interventions was modestly sensitive to the prevalence of COVID-19, diagnostic test sensitivity, and testing costs. Conclusion: Screening all incoming travellers, testing symptomatic persons, and isolating positives (Option 2) was the most cost-effective option. A higher COVID-19 prevalence among incoming travellers increased cost-effectiveness of airport-specific interventions. This model could be used to evaluate prevention options at the airport for COVID-19 and other infectious diseases with similar requirements for control.

1 June 2025 in Leprosy Review
Verified
Journal Article
Open access
PDF file
STStavia Turyahabwe
Stavia Turyahabwe
RKRose Kengonzi
Rose Kengonzi
JKJoseph Kawuma
Joseph Kawuma
LGLisa Gerwing
Lisa Gerwing
BMBamuloba Muzamiru
Bamuloba Muzamiru
GAGeofrey Amanya
Geofrey Amanya
Background Uganda undertook a six-month national-level campaign to improve access to TB and leprosy services following the negative impacts of COVID-19 on health care services. This paper aims to present the results of a detailed case analysis of all patients with leprosy from 2022 to 2023 and to illustrate the benefit of integrating leprosy active case finding in the tuberculosis awareness, screening, testing, treatment, and prevention (CAST) campaign. Methods The activities implemented during the campaign included community awareness raising and screening and management of suspected TB and Leprosy patients. Data collected at the community level was aggregated at the facility level and entered in an online system. Data analysis from a custom database created for the CAST campaign was conducted. Results Three episodes of the CAST campaign were carried out in March 2022, September 2022, and March 2023. Of the 6,715,810 individuals screened for TB and leprosy, 55% were female. 14,560 were diagnosed with TB. In addition, 4302 individuals had skin lesions suspicious of leprosy, and 5% (196) were diagnosed with leprosy and started on treatment. The overall proportion of leprosy patients contributed by the campaign was 49% (196/399), 60% being from the West Nile region. Conclusions The CAST campaign is an innovative strategy to improve TB and Leprosy control in Uganda. It is crucial to continuously monitor and evaluate the campaign progress, making adjustments as needed to ensure its success. The results also justify the integration of TB and Leprosy programmes particularly in remote settings with high disease burdens.